Skip to content

About us
Team
- Founders
- Management
Study Area
Pipeline & therapeutic areas
Partnerships
News
Contact

Origins

Since 1995, we are focusing our work on infectious and inflammatory dermatology.

About us Origins Objectives Discoveries and patents Strategy Location

News SkinDermic announces very good results of the SDK 001 compound in the treatment of Kaposis sarcoma.SkinDermic announces very good results of the SDA 001 compound in the treatment of acne.Skindermic signed with SATT Idfinnov

About us
Origins
Objectives
Discoveries and patents
Strategy
Location

Team
Founders
Management

Study Area
Acne
Kaposi’s Sarcoma
Skin-Depigmenting

Pipeline & therapeutic areas

Partnerships

News

Contact

©2024 SkinDermic - Legal Notice - LinkedIn